Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Dee Lin, Dominic Pilon, Maryia Zhdanava, Kruti Joshi, Marie-Hélène Lafeuille, Aurélie Côté-Sergent, Maude Vermette-Laforme & Patrick Lefebvre. (2021) Medication adherence, healthcare resource utilization, and costs among Medicaid beneficiaries with schizophrenia treated with once-monthly paliperidone palmitate or once-every-three-months paliperidone palmitate. Current Medical Research and Opinion 37:4, pages 675-683.
Read now
Read now
Prakash Masand, Changsu Han & Chi-Un Pae. (2017) Will the Proteus sensor enhance adherence to aripiprazole or other antipsychotics?. Expert Review of Neurotherapeutics 17:4, pages 319-321.
Read now
Read now
Yakup Albayrak, Cuneyt Unsal & Murat Beyazyuz. (2013) Relationships between Use of Long Acting Antipsychotics and Sociodemographic and Clinical Characteristics of Patients with Schizophrenia. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 23:2, pages 171-179.
Read now
Read now
Laura J. Laakso. (2011) Motivational Interviewing: Addressing Ambivalence to Improve Medication Adherence in Patients with Bipolar Disorder. Issues in Mental Health Nursing 33:1, pages 8-14.
Read now
Read now
Min-Hyeon Park, Changsu Han, Chi-Un Pae, Soo-Jung Lee, Ashwin A Patkar, Praksh S Masand & Wolfgang W Fleischhacker. (2011) Aripiprazole treatment for patients with schizophrenia: from acute treatment to maintenance treatment. Expert Review of Neurotherapeutics 11:11, pages 1541-1552.
Read now
Read now
Bawo Onesirosan James & Joyce Ohiole Omoaregba. (2011) Prevalence and predictors of poor medication adherence among out-patients at a psychiatric hospital in Benin City, Nigeria. International Journal of Psychiatry in Clinical Practice 15:1, pages 27-34.
Read now
Read now
Articles from other publishers (13)
Ching-Hua Lin, Hung-Yu Chan, Fu-Chiang Wang & Chun-Chi Hsu. (2022) Time to rehospitalization in involuntarily hospitalized individuals suffering from schizophrenia discharged on long-acting injectable antipsychotics or oral antipsychotics. Therapeutic Advances in Psychopharmacology 12, pages 204512532210791.
Crossref
Crossref
Markku Lähteenvuo & Jari Tiihonen. (2021) Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations. Drugs 81:11, pages 1273-1284.
Crossref
Crossref
Giovanni OstuzziFederico BertoliniCinzia Del GiovaneFederico TedeschiChiara BovoChiara GastaldonMichela NoséFilippo OgheriDavide PapolaMarianna PurgatoGiulia TurriniChristoph U. CorrellCorrado Barbui. (2021) Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis. American Journal of Psychiatry 178:5, pages 424-436.
Crossref
Crossref
Valentina Corigliano, Anna Comparelli, Iginia Mancinelli, Benedetta Montalbani, Dorian A. Lamis, Antonella De Carolis, Denise Erbuto, Paolo Girardi & Maurizio Pompili. (2018) Long-Acting Injectable Second-Generation Antipsychotics Improve Negative Symptoms and Suicidal Ideation in Recent Diagnosed Schizophrenia Patients: A 1-Year Follow-up Pilot Study. Schizophrenia Research and Treatment 2018, pages 1-7.
Crossref
Crossref
Giovanni Ostuzzi, Maria Angela Mazzi, Samira Terlizzi, Federico Bertolini, Andrea Aguglia, Francesco Bartoli, Paola Bortolaso, Camilla Callegari, Mariarita Caroleo, Giuseppe Carrà, Mariangela Corbo, Armando D’Agostino, Chiara Gastaldon, Claudio Lucii, Fabio Magliocco, Giovanni Martinotti, Michela Nosé, Edoardo Giuseppe Ostinelli, Davide Papola, Marco Piero Piccinelli, Alberto Piccoli, Marianna Purgato, Tommaso Tabacchi, Giulia Turrini, Mirella Ruggeri & Corrado Barbui. (2018) Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy. PLOS ONE 13:8, pages e0201371.
Crossref
Crossref
Giovanni Ostuzzi, Irene Bighelli, Ryuhei So, Toshi A. Furukawa & Corrado Barbui. (2017) Does formulation matter? A systematic review and meta-analysis of oral versus long-acting antipsychotic studies. Schizophrenia Research 183, pages 10-21.
Crossref
Crossref
G. Ostuzzi & C. Barbui. (2015) Comparative effectiveness of long-acting antipsychotics: issues and challenges from a pragmatic randomised study. Epidemiology and Psychiatric Sciences 25:1, pages 21-23.
Crossref
Crossref
Ajeet B Singh, Andrew A Nierenberg, Lakshmi N Yatham & Michael Berk. (2014) Atypical antipsychotic agents; Peas in a pod or chalk and cheese?. BMC Medicine 12:1.
Crossref
Crossref
Takefumi Suzuki, Hiroyuki Uchida, Hiroyoshi Takeuchi, Takashi Tsuboi, Jinichi Hirano & Masaru Mimura. (2014) A review on schizophrenia and relapse-a quest for user-friendly psychopharmacotherapy. Human Psychopharmacology: Clinical and Experimental 29:5, pages 414-426.
Crossref
Crossref
J‐F. CHENG, X‐Y. HUANG, Y‐S. HSU & C‐H. SU. (2011) Influencing factors of community mental health nurses caring for people with schizophrenia in Taiwan. Journal of Psychiatric and Mental Health Nursing 19:4, pages 319-326.
Crossref
Crossref
Kim Helmus, Maike Bezemer, Marieke Pijnenborg & Cees Slooff. (2011) Shared decision making binnen de zorg voor mensen met psychose. Psychopraktijk 3:6, pages 30-34.
Crossref
Crossref
Prakash Masand, Cedric O'Gorman & Francine S. Mandel. (2011) Clinical Global Impression of Improvement (CGI-I) as a valid proxy measure for remission in schizophrenia: Analyses of ziprasidone clinical study data. Schizophrenia Research 126:1-3, pages 174-183.
Crossref
Crossref
Suzanne M. Hardeman & Meera Narasimhan. (2010) Adherence According to Mary Poppins: Strategies to Make the Medicine Go Down. Perspectives in Psychiatric Care 46:1, pages 3-13.
Crossref
Crossref